That is a telling graph, which demonstrates - via that yellow shaded gap - just how totally out-of-whack the share price was over the preceding five years, relative to underlying earnings.
And yes, it is hard to disagree with your statement that about earnings having caught up with the share price. Finally.
The final penny to drop will be the next two financial reports, which will need to show that CSL's vaccine business retains some traction in the face of signs of vaccine wariness/fatigue is some societies.
.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$241.22 |
Change
0.440(0.18%) |
Mkt cap ! $116.8B | |||
| Open | High | Low | Value | Volume |
| $242.75 | $243.98 | $240.50 | $145.1M | 600.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 704 | $241.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $241.22 | 397 | 2 |
View Market Depth
| Last trade - 16.21pm 24/06/2025 (20 minute delay) ? |
| CSL (ASX) Chart |